RxDoctor Payments Data

Jennifer Wu

Hematology & Oncology · Brooklyn, NYNPI 1417997412

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $3,425 of the $4,047 with a category attached, or 84.6%. AstraZeneca accounts for 85.1% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2024 at $3,168 and has fallen 90.0% since, to $318 in 2025.

$4,047in general payments, 2019–2025

Across 15 payments — averaging $269.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$3K
  • Cardinal Health 110 LLC$275
  • Daiichi Sankyo Inc.$200
  • Johnson & Johnson$81
  • Amgen$30
  • Merck$18
$790,592in research payments, 2019–2025

Across 43 payments — averaging $18,386 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AstraZeneca$419K
  • Genentech, Inc.$291K
  • E.r. Squibb & Sons, L.L.C.$76K
  • Bristol Myers Squibb$4K

What the payments were for

  • Consulting fees$3,42585%
  • Speaking & faculty fees$45011%
  • Food & beverage$1113%
  • Education$612%

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca(2 entities)8$3,443
Cardinal Health 110 LLC1$275
Daiichi Sankyo Inc.1$200
Johnson & Johnson3$81
Amgen1$30
Merck1$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,047 in reported general payments places this provider in the 60th percentile of 967 hematology & oncology providers in New York.

See all hematology & oncology providers in New York →

Most prescribed under Part D

DrugClaimsCost to plans & patients
Anastrozole15$124
Gabapentin13$119

Paid to pharmacies, not to this prescriber.

Other hematology & oncology in Brooklyn

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →